Trailhead Biosystems Inc. ( a biotechnology company advancing human cell innovation, has added $20 million in new funding, expanding the financing announced in May 2025 to $40 million. The funding ...

Additional funding of $20 million accelerates commercialization of Trailhead's iPSC-derived human cell and media products.

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...

Researchers at the University of British Columbia developed a reliable method to produce helper T cells from stem cells by ...

The funding, part of a new ARPA-H bioprinting initiative, aims to create transplant-ready organs—potentially within ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf," cell therapies for serious medical conditions, ...

GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced ...

For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...

Researchers say study findings may lead to a more promising future for cell therapy targeting stroke and other neurological disorders.

Somite, an AI-native TechBio company building the first universal virtual cell-signaling model, today announced its new identity, Cellular Intelligence. This rebrand reflects the company's vision to ...